Proteolysis targeting chimera - Wikipedia
A proteolysis targeting chimera (PROTAC) [2] is a molecule that can remove specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor, a PROTAC works by inducing selective …
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
PROteolysis TArgeting Chimera (PROTAC) technology targets cellular proteins for degradation by co-opting the Ubiquitin Proteasome System.
Lessons learned in linking PROTACs from discovery to the clinic
Dec 12, 2025 · Proteolysis targeting chimeras (PROTACs) are an emerging platform in drug discovery with the potential to unlock novel pharmacology and tackle undruggable targets.
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Apr 1, 2019 · New modalities that operate using alternative MOAs are essential for tapping into the “undruggable” proteome. The PROteolysis Targeting Chimera (PROTAC) technology provides an …
PROTACs and Molecular Glues - AstraZeneca
Dec 24, 2019 · PROTACs are bifunctional molecules with two heads connected by a linker. One ‘head’ of the molecule selectively binds the target protein and a second ‘head’ of the molecule recruits a …
What are PROTACs? Mechanisms, advantages, and challenges
Oct 22, 2025 · Enter PROTACs, or proteolysis targeting chimeras —a new class of small-molecule therapeutics that harness the cell’s degradation machinery to selectively eliminate disease-causing …
PROTACs: Past, Present and Future - PMC - National Center for ...
Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules consisting of one ligand that binds to a protein of interest (POI) and another that can recruit an E3 ubiquitin ligase.
An overview of PROTACs: a promising drug discovery paradigm
Dec 20, 2022 · PROTACs are heterobifunctional molecules that degrade target proteins by hijacking the ubiquitin–proteasome system. Currently, about 20–25% of all protein targets are being studied, and …
PROTACs: Current and Future Potential as a Precision Medicine …
Apr 2, 2024 · Proteolysis targeting chimeras (PROTAC) are an emerging precision medicine strategy, which targets key proteins for proteolytic degradation to ultimately induce cancer cell killing.
What Are Protacs - ScienceInsights
Mar 24, 2026 · PROTACs (Proteolysis Targeting Chimeras) are a new class of experimental drugs designed to destroy disease-causing proteins rather than simply blocking them. Traditional drugs …